Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

Source:http://linkedlifedata.com/resource/pubmed/id/2328092

Download in:

View as

General Info

PMID
2328092